MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-12-2025
Microbot Medical Market Cap 2011-2026 | MBOT
As of January 02, 2026 Microbot Medical has a market cap of $ 20.4 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Microbot Medical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.7 M | 16.8 M | 39.2 M | 60.7 M | 38.2 M | 24.1 M | 34.3 M | 69.3 M | 33.5 M | 70.2 M | 63 M | 48.4 M | 14.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 70.2 M | 11.7 M | 40.3 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical instruments industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Baxter International
BAX
|
17.3 B | $ 19.11 | -0.98 % | $ 9.75 B |  USA |
 |
Becton, Dickinson and Company
BDX
|
56.2 B | $ 194.07 | -0.8 % | $ 55.8 B | USA |
 |
Luminex Corporation
LMNX
|
1.27 B | - | - | $ 1.75 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
9.68 M | $ 8.64 | -18.34 % | $ 174 M | USA |
 |
Akers Biosciences, Inc.
AKER
|
809 K | - | -9.52 % | $ 20.6 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
727 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
2.27 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
152 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
6.07 B | - | -0.05 % | $ 10.3 B | USA |
 |
Harvard Bioscience
HBIO
|
188 M | $ 0.67 | 1.66 % | $ 28.4 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
15.6 B | - | -0.02 % | $ 16.3 B | USA |
 |
Repro Med Systems
KRMD
|
96.7 M | $ 5.81 | 2.11 % | $ 265 M | USA |
 |
Alcon
ALC
|
42.6 B | $ 78.81 | -0.64 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
1.91 B | $ 39.56 | -1.54 % | $ 1.86 B | USA |
 |
Atrion Corporation
ATRI
|
639 M | - | - | $ 810 M | USA |
 |
ICU Medical
ICUI
|
3.65 B | $ 142.67 | -1.36 % | $ 3.48 B | USA |
 |
electroCore
ECOR
|
29.4 K | $ 4.49 | -3.55 % | $ 24.8 K | USA |
 |
iRhythm Technologies
IRTC
|
3.49 B | $ 177.44 | -0.63 % | $ 5.54 B | USA |
 |
AngioDynamics
ANGO
|
355 M | $ 12.84 | -1.23 % | $ 525 M | USA |
 |
Isoray
ISR
|
24.5 M | - | 0.03 % | $ 108 M | USA |
 |
The Cooper Companies
COO
|
16.3 B | $ 81.96 | -0.62 % | $ 16.3 B | USA |
 |
Glaukos Corporation
GKOS
|
4.3 B | $ 112.91 | -1.16 % | $ 5.47 B | USA |
 |
LeMaitre Vascular
LMAT
|
2.07 B | $ 81.1 | -2.3 % | $ 1.82 B | USA |
 |
Haemonetics Corporation
HAE
|
3.06 B | $ 80.15 | -1.02 % | $ 4.03 B | USA |
 |
InfuSystem Holdings
INFU
|
146 M | $ 8.97 | 0.67 % | $ 185 M | USA |
 |
Masimo Corporation
MASI
|
8.96 B | $ 130.06 | -0.77 % | $ 6.93 B | USA |
 |
OraSure Technologies
OSUR
|
259 M | $ 2.42 | -2.02 % | $ 180 M | USA |
 |
Merit Medical Systems
MMSI
|
5.94 B | $ 88.14 | -0.47 % | $ 5.13 B | USA |
 |
Intuitive Surgical
ISRG
|
203 B | $ 566.36 | -1.09 % | $ 201 B | USA |
 |
Milestone Scientific
MLSS
|
69.4 M | $ 0.27 | -0.22 % | $ 21.5 M | USA |
 |
Nephros
NEPH
|
22.5 M | $ 4.88 | 3.39 % | $ 50.7 M | USA |
 |
Stereotaxis
STXS
|
215 M | $ 2.3 | -0.22 % | $ 186 M | USA |
 |
NeuroMetrix
NURO
|
8.71 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
3.68 B | $ 21.71 | -0.91 % | $ 3.74 B | USA |
 |
STERIS plc
STE
|
24.2 B | $ 253.52 | -0.76 % | $ 25 B | USA |
 |
Pro-Dex
PDEX
|
150 M | $ 38.48 | -0.3 % | $ 127 M | USA |
 |
Predictive Oncology
POAI
|
8.29 M | - | - | $ 32.4 M | USA |
 |
Utah Medical Products
UTMD
|
247 M | $ 55.96 | -0.57 % | $ 203 M | USA |
 |
Pulse Biosciences
PLSE
|
418 M | $ 13.73 | 0.22 % | $ 660 M | USA |
 |
ResMed
RMD
|
35.1 B | $ 240.87 | -0.91 % | $ 35.2 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
3.5 B | $ 11.43 | 0.35 % | $ 2.32 B | USA |
 |
Repligen Corporation
RGEN
|
10.8 M | $ 163.86 | -1.64 % | $ 9.13 M | USA |
 |
BioLife Solutions
BLFS
|
1.14 B | $ 24.18 | -1.95 % | $ 1.11 B | USA |
 |
Retractable Technologies
RVP
|
21 M | $ 0.77 | -0.63 % | $ 23.1 M | USA |
 |
STAAR Surgical Company
STAA
|
832 M | $ 23.09 | -0.52 % | $ 1.13 B | USA |
 |
Teleflex Incorporated
TFX
|
6.21 B | $ 122.04 | 0.35 % | $ 5.72 B | USA |
 |
West Pharmaceutical Services
WST
|
15.4 B | $ 275.14 | -0.62 % | $ 20.1 B | USA |